Finoriq research workspace
BIO-TECHNE Corp (TECH) Institutional Holdings & 13F Ownership
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments. Review TECH institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
- Company
- BIO-TECHNE Corp (TECH)
- Ticker
- TECH
- Market Cap
- $11.2B
- Latest Price
- $71.63
- Industry
- Biotech & Pharma
BIO-TECHNE Corp (TECH) Top Institutional Holders
Top current 13F holders indexed for BIO-TECHNE Corp (TECH). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Lee AinslieCIK 0000934639 | $247.7M | 2.9% | Filing2026-05-15 |
| 2 | Henry EllenbogenCIK 0001798849 | $232.9M | 2.4% | Filing2026-05-15 |
| 3 | Ruane Cunniff (advisor level)CIK 0001720792 | $177.3M | 2.9% | Filing2026-05-15 |
| 4 | Mairs & Power FundsCIK 0001070134 | $143.7M | 1.5% | Filing2026-05-14 |
| 5 | Wallace WeitzCIK 0000883965 | $34.1M | 2.4% | Filing2026-05-14 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.